Suryaa Now International Desk: In the field of medicine, the research done by leading pharma giant AstraZeneca has once again registered great achievements. Stomach cancer (stomach... In the field of medicine, the research done by leading pharma giant AstraZeneca has once again registered great achievements. A new drug developed by AstraZeneca for the treatment of stomach cancer has passed a major milestone in clinical trials.
Company sources revealed that the drug has shown excellent results in significantly extending overall survival in patients. The drug has successfully met its targets in late-stage trials in advanced stomach cancer patients. Medical experts believe that this research is a big step towards providing effective treatment for stomach cancer which is one of the deadliest diseases worldwide. Compared to traditional treatment methods, this new drug has shown better performance in increasing the life expectancy of patients and suppressing the severity of the disease.
Clinical experts claim that this therapy is highly effective in stopping the spread of malignant cancer cells. In view of these positive results, AstraZeneca will soon apply for commercial approvals from the relevant regulatory bodies. If this drug becomes available, health experts are confident that millions of stomach cancer sufferers around the world will get better quality of life and new hope.
